Product Information
Name:Durvalumab
Brand:Biosynth
Description:Durvalumab is a human immunoglobulin G1 (IgG1) monoclonal antibody that binds to PD-L1, a protein expressed on the surface of tumor cells. Durvalumab is being studied in combination with tremelimumab (another anti-PD-L1 antibody) for use as an antitumor agent. The combination of durvalumab and tremelimumab has been shown to have an antitumor response in mice with bowel disease. This drug has been shown to have an immune-modulating effect in combination therapy groups.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:1,000 g/mol
Purity:Min. 95%
Color/Form:Powder
Technical inquiry about: Durvalumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.